Christopher H. van Dyck
Yale University(US)Alzheimer’s Disease Neuroimaging Initiative(US)
Publications by Year
Research Areas
Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research, Functional Brain Connectivity Studies, Neuroscience and Neuropharmacology Research, Advanced Neuroimaging Techniques and Applications
Most-Cited Works
- → Lecanemab in Early Alzheimer’s Disease(2022)4,787 cited
- → Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment(2005)1,852 cited
- → Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease(2022)1,255 cited
- → Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study.(2000)987 cited
- → A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease(2009)735 cited
- → A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease(2015)678 cited